126 related articles for article (PubMed ID: 11839662)
21. [Comparative characteristic of the methods of immunocytochemistry and immunomagnetic separation for detection of cytokeratin-positive cells in bone marrow and lymph nodes].
Lebedinskaia OV; Shubina IZh; Donenko F; Pirogov AV; Kiselevskiĭ MV
Morfologiia; 2007; 132(4):81-6. PubMed ID: 17969436
[TBL] [Abstract][Full Text] [Related]
22. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
Lohsiriwat V; Thavichaigarn P; Awapittaya B
J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
[TBL] [Abstract][Full Text] [Related]
23. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.
Mukai M; Sato S; Nishida T; Komatsu N; Shiba K; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(6):1753-8. PubMed ID: 14534691
[TBL] [Abstract][Full Text] [Related]
24. Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system.
Kraeft SK; Sutherland R; Gravelin L; Hu GH; Ferland LH; Richardson P; Elias A; Chen LB
Clin Cancer Res; 2000 Feb; 6(2):434-42. PubMed ID: 10690521
[TBL] [Abstract][Full Text] [Related]
25. Immunomagnetic enrichment and detection of micrometastases in colorectal cancer: correlation with established clinical parameters.
Weihrauch MR; Skibowski E; Koslowsky TC; Voiss W; Re D; Kuhn-Regnier F; Bannwarth C; Siedek M; Diehl V; Bohlen H
J Clin Oncol; 2002 Nov; 20(21):4338-43. PubMed ID: 12409333
[TBL] [Abstract][Full Text] [Related]
26. [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):753-7. PubMed ID: 17366787
[TBL] [Abstract][Full Text] [Related]
27. The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy.
Eide N; Faye RS; Høifødt HK; Sandvik L; Qvale GA; Faber R; Jebsen P; Kvalheim G; Fodstad Ø
Pathol Oncol Res; 2019 Jan; 25(1):255-262. PubMed ID: 29098521
[TBL] [Abstract][Full Text] [Related]
28. The inflammatory response within Dukes' B colorectal cancers: implications for progression of micrometastases and patient survival.
Murphy J; O'Sullivan GC; Lee G; Madden M; Shanahan F; Collins JK; Talbot IC
Am J Gastroenterol; 2000 Dec; 95(12):3607-14. PubMed ID: 11151900
[TBL] [Abstract][Full Text] [Related]
29. Spectrum of cytokeratin-positive cells in the bone marrows of colorectal carcinoma patients.
Shetye JD; Liljefors ML; Emdin SO; Frödin JE; Strigård K; Mellstedt HT; Porwit A
Anticancer Res; 2004; 24(4):2375-83. PubMed ID: 15330187
[TBL] [Abstract][Full Text] [Related]
30. Disseminated tumour cells in bone marrow of patients with uveal melanoma.
Eide N; Hoifødt HK; Nesland JM; Faye RS; Qvale GA; Faber RT; Jebsen P; Kvalheim G; Fodstad Ø
Acta Ophthalmol; 2013 Jun; 91(4):343-8. PubMed ID: 22632270
[TBL] [Abstract][Full Text] [Related]
31. Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer.
Vlems FA; Diepstra JH; Punt CJ; Ligtenberg MJ; Cornelissen IM; van Krieken JH; Wobbes T; van Muijen GN; Ruers TJ
Br J Surg; 2003 Aug; 90(8):989-95. PubMed ID: 12905553
[TBL] [Abstract][Full Text] [Related]
32. Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.
El-Awady S; Lithy R; Morshed M; Khafagy W; Abd Monem H; Waleed O; Badr S; Fekry A; El Nakeeb A; Ghazy H; El Yamany M; Metwally T; El-Arman M; Farid M
Hepatogastroenterology; 2009; 56(90):361-6. PubMed ID: 19579599
[TBL] [Abstract][Full Text] [Related]
33. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
34. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow metastasis in nasopharyngeal cancer: early detection using EBER1 in situ hybridization.
Chen TY; Tsai ST; Jin YT; Su WC; Tsao CJ
Anticancer Res; 1999; 19(1B):885-8. PubMed ID: 10216511
[TBL] [Abstract][Full Text] [Related]
36. Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro.
Zigeuner RE; Riesenberg R; Pohla H; Hofstetter A; Oberneder R
J Urol; 2000 Nov; 164(5):1834-7. PubMed ID: 11025779
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
38. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood.
Naume B; Borgen E; Beiske K; Herstad TK; Ravnås G; Renolen A; Trachsel S; Thrane-Steen K; Funderud S; Kvalheim G
J Hematother; 1997 Apr; 6(2):103-14. PubMed ID: 9131439
[TBL] [Abstract][Full Text] [Related]
39. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
40. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
